NURS-6521C Advanced Pharmacology

Certainly, here’s the information with all headings and subheadings unboldened:

This document provides information about the course “NURS-6521C Advanced Pharmacology” offered by Walden University. It outlines various outcomes, goals, and objectives related to the course content and student learning. The course aims to empower nursing professionals with knowledge and skills for effective prescription drug management.

University Outcomes:
Walden University aims to produce graduates who can bring about positive social change, utilize their knowledge to impact their profession and society, exhibit lifelong learning, apply learning to solve workplace challenges, demonstrate information literacy, understand inquiry methods in their field, practice ethical integrity, communicate effectively, and support diversity.

Social Change Features:
1. Scholarship: Ability to conduct reliable research and assess others’ research findings.
2. Systems Thinking: Capability to analyze complex problems and offer solutions.
3. Reflection: Skill in self-evaluation and team assessment for better outcomes.
4. Practice: Ability to manage practical projects that improve the common good.
5. Collaboration: Skill to work with stakeholders and partners on joint projects.
6. Advocacy: Skill in raising awareness and encouraging responses to issues.
7. Civic & Political Engagement: Ability to work with policymakers for improvements.
8. Ethics: Development of personal values and ethical behavior.
9. Leadership: Skill to guide, empower, and inspire others for the common good.

Program Outcomes (Master of Science in Nursing – MSN):
These outcomes highlight the development of nursing leaders who can improve healthcare quality, assess and address health disparities, communicate effectively, promote diversity, and implement nursing roles for quality improvement.

School of Nursing Goals:
1. Enhance nursing professionals’ growth, development, and academic achievement.
2. Build on learners’ nursing knowledge and skills in an educational environment.
3. Educate nursing professionals while upholding nursing standards.
4. Integrate nursing theories, research, and evidence-based practice.
5. Prepare nursing leaders for social change locally, nationally, and globally.

AACN Masters Essentials:
These essentials cover background knowledge, leadership, quality improvement, scholarship integration, informatics, health policy, collaboration, prevention, and master’s-level nursing practice.

Course Outcomes:
The course focuses on evaluating patient factors in pharmacokinetics/pharmacodynamics, analyzing drug treatments for disorders, considering patient drug therapy plans, evaluating drug therapy outcomes, applying decision-making strategies for drug use, and assessing ethical and legal aspects of drug prescription.

Weekly Objectives Alignment Chart:
This chart aligns weekly activities with various outcomes, program goals, AACN essentials, social change features, and university outcomes. It helps track how each topic in the course connects to broader educational objectives.

The document contains information on different modules covering topics such as pharmacotherapy, cardiovascular and respiratory systems, gastrointestinal and hepatobiliary systems, endocrine system, neurological and musculoskeletal systems, psychological disorders, women’s and men’s health, infections, hematologic systems, and pediatrics. Each module outlines objectives and learning outcomes related to patient evaluation, treatment strategies, and decision-making in the context of various disorders and conditions.

© 2021 Walden University, LLC Page 1 of 10
Outcomes/Alignment Chart
NURS 6521: Advanced Pharmacology
University Outcomes
Walden University strives to produce graduates with the knowledge, skills, and abilities to:
I. Facilitate positive social change where they work, in their communities, and in society.
II. Use their knowledge to positively impact their profession, communities, and society.
III. Demonstrate a commitment to lifelong learning.
IV. Apply their learning to specific problems and challenges in their workplace and professional settings.
V. Demonstrateinformation literacy.*
VI. Demonstrate an understanding of the methods of inquiry used in their professional or academic field.
VII. Practice legal and ethical integrity in their professional work.
VIII. Effectively communicate their ideas and the rationale behind them to others.
IX. Support diversity and multiculturalism within their profession, communities, and society.
*Information literacy is defined as the ability to know when there is a need for information, and being able to identify, locate, evaluate, and effectively use that information for the
issue or problem at hand.
Social Change Features
1. Scholarship—The ability to employ trustworthy, effective research strategies that could be used to find answers to
significant questions along with the ability to locate and assess the research findings and claims of others
2. Systems Thinking—The ability to analyze a set of inter-related causes and effects which can be applied to finding
solutions to complex social problems
© 2021 Walden University, LLC Page 2 of 10
3. Reflection—The ability to examine and assess one’s owns skills, strengths, weaknesses, and contributions and to
similarly evaluate one’s team and partners in ways that can contribute to improved efficacy
4. Practice—The skills needed to plan, execute, manage, and evaluate a practical project to improve conditions or
seize an opportunity that would advance the common good
5. Collaboration—The ability to identify and connect with stakeholders, resources, experts, useful networks and
potential partners combined with the personal skills needed to work with others on joint projects
6. Advocacy—The ability to deploy strategies and actions appropriate to raising awareness in others around an issue
or opportunity that calls for a response from them
7. Civic & Political Engagement—The skill to work with policy-makers at various level in government, professional
organizations, and institutions to bring about improvement in rules, laws, policies, or practices
8. Ethics—The development of and commitment to a personal set of values, principles, attitudes, and personal
responses in relating to one’s own responsibilities, to others, and to the wider world
9. Leadership—The skill to guide, empower, facilitate, and assess the work of others along with the ability to inspire
and motivate their efforts toward the common good
Program Outcomes: Master of Science in Nursing (MSN)
1. Synthesize organizational/systems leadership for cost-effective specialist nursing practice that contributes to highquality health care delivery, advancement of the nursing profession, and social change
2. Critique evidence-based literature drawing from diverse theoretical perspectives and pertinent research to guide
decision-making that demonstrates best practices for specialist nursing practice in a global society
3. Integratively assess, diagnose, plan, implement, and evaluate cost-effective health care strategies that reduce
health disparities by patient/population advocacy for access to specialist nursing care
4. Demonstrate the ability to effectively communicate using audience-specific oral, written, and information technology
for professional delivery of specialist nursing care
5. Evaluate health needs of diverse populations for necessary teaching/coaching functions based on specialist
nursing knowledge to restore/promote health and prevent illness/injury
6. Exhibit ongoing commitment to professional development and value of nursing theories/ethical principles (altruism,
autonomy, human dignity, integrity, social justice) in accordance with ethically responsible, legally accountable,
specialist nursing practice
7. Implement specialist nursing roles to promote quality improvement of patient-centered care in accordance with
professional practice standards that transform health outcomes for diverse populations
© 2021 Walden University, LLC Page 3 of 10
SoN Goals
1. To empower the nursing professional through academic advancement that enhances personal growth, professional
development, and academic achievement.
2. To create an educational environment where learners are to build on their existing transformational and
professional nursing knowledge, skills, and integrative abilities.
3. To educate the nursing professional with consideration for the complex needs of the diverse learner while
upholdingprofessional nursing standards.
4. To encourage learners to integrate biopsychosocial, nursing and health theories, research, and evidence-based
practice that exemplifies professional nursing standards.
5. To prepare professional nursing leaders who are empowered to promote social change for individuals, groups, and
organizations locally, nationally, and globally.
AACN Masters Essentials
1. Background for Practice from Sciences and Humanities
2. Organizational andSystems Leadership
3. Quality Improvement and Safety
4. Translating and Integrating Scholarship into Practice
5. Informatics and Healthcare Technologies
6. Health Policy and Advocacy
7. Interprofessional Collaboration for Improving Patient and Population Health Outcomes
8. Clinical Prevention and Population Health for Improving Health
9. Master’s-Level NursingPractice
Course Outcomes
1. Evaluate the impact of patient factors on pharmacokinetic and pharmacodynamic processes
2. Analyze pharmacotherapeutic treatments for body system disorders and the effects they have on patient
outcomes
3. Analyze factors that impact patient drug therapy plans
4. Evaluate the impact of drug therapy on patient health outcomes
© 2021 Walden University, LLC Page 4 of 10
5. Apply decision-making strategies for the appropriate use of drugs based on classifications, indications, patient
factors, and pathophysiology
6. Evaluate ethical and legal implications of prescribing drugs
Weekly Objectives Alignment Chart
Key
D: Discussion
A:Application
ME: Midterm Exam
FE: Final Exam
Module 1: Basic
Pharmacotherapeutic
Concepts/Ethicaland
Legal Aspects of
Prescribing
(Week 1)
Met in
(D#/A#/Other)
Course
Outcome(s)
Program
Outcome(s)
SoNGoals AACN
Masters
Essentials
Social
Change
Features
University
Outcome(s)
Analyze factors that
influence
pharmacokineticand
pharmacodynamic
processes in patients
D 1 3 1, 2, 3, 4, 5 1, 3, 6, 7, 9 1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, V, VI,
VII, IX
Assess patient factors
and history to develop
personalized plans of
care
D 1, 2, 3 2, 3, 5 1, 2, 3, 4, 5 1, 2, 3, 4,
5, 6, 7, 8, 9
1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, IV, V,
VI, VII, VIII, IX
Evaluate ethical and
legal implications related
to prescribing drugs
A 5, 6 2, 6 1, 2, 3, 4, 5 1, 2, 4, 5,
6, 8
1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, IV, V,
VI, VII, VIII, IX
Analyze ethical and A 6 6 1, 2, 3, 4, 5 1, 4, 5, 6 1, 2, 3, 4, I, III, V, VI, VII,
© 2021 Walden University, LLC Page 5 of 10
legal practices of
prescribing drugs
5, 6, 7, 8,
9
VIII, IX
Analyze strategies to
address disclosure and
nondisclosure
A 6 2, 6 1, 2, 3, 4, 5 1, 2, 4, 5,
6, 8
1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, IV, V,
VI, VII, VIII, IX
Justifyadvanced
practice nurse strategies
to guide prescription
drugdecision-making
A 5, 6 2, 3, 6, 7 1, 2, 3, 4, 5 1, 2, 3, 4,
5, 6, 7, 8, 9
1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, IV, V,
VI, VII, VIII, IX
Analyze the process of
writing prescriptions to
avoid medication errors
A 5, 6 2, 6, 7 1, 2, 3, 4, 5 1, 2, 3, 4,
5, 6, 8, 9
1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, IV, V,
VI, VII, VIII, IX
Module 2:
Cardiovascular and
Respiratory Systems
(Weeks 2-3)
Met in
(D#/A#/Other)
Course
Outcome(s)
Program
Outcome(s)
SoNGoals AACN
Masters
Essentials
Social
Change
Features
University
Outcome(s)
Analyze the influence of
patient factors on
pharmacokineticand
pharmacodynamic
processes
A1, A2 1 3 1, 2, 3, 4, 5 1, 3, 6, 7, 9 1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, V, VI,
VII, IX
Analyze the impact of
changes in
pharmacokineticand
pharmacodynamic
processes on patient
drug therapies
A1, A2 1, 2 2, 3 1, 2, 3, 4, 5 1, 2, 3, 4,
6, 7, 8, 9
1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, IV, V,
VI, VII, VIII, IX
Evaluate drug therapy
plans for cardiovascular
disorders
A1 2, 5 3, 5 1, 2, 3, 4, 5 1, 3, 4, 5,
6, 7, 8, 9
1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, V, VI,
VII, VIII, IX
Evaluate the impact of
patient factors on the
A2 2, 3 3 1, 2, 3, 4, 5 1, 3, 6, 7, 9 1, 2, 3, 4,
5, 6, 7, 8,
I, II, III, V, VI,
VII, IX
© 2021 Walden University, LLC Page 6 of 10
effects of prescribed
drugs for asthma
9
Evaluate drug therapy
plans for asthma
A2 2, 3 3 1, 2, 3, 4, 5 1, 3, 6, 7, 9 1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, V, VI,
VII, IX
Analyze the impact of
asthma treatments on
patients
A2 2, 3 3 1, 2, 3, 4, 5 1, 3, 6, 7, 9 1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, V, VI,
VII, IX
Analyze the stepwise
approach to asthma
treatment and
management
A2 2, 5 2, 3, 5 1, 2, 3, 4, 5 1, 2, 3, 4,
5, 6, 7, 8, 9
1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, IV, V,
VI, VII, VIII, IX
Module 3:
Gastrointestinaland
Hepatobiliary Systems
(Week 4)
Met in
(D#/A#/Other)
Course
Outcome(s)
Program
Outcome(s)
SoNGoals AACN
Masters
Essentials
Social
Change
Features
University
Outcome(s)
Evaluate diagnoses for
patients with
gastrointestinaland
hepatobiliarydisorders
A 2 3 1, 2, 3, 4, 5 1, 3, 6, 7, 9 1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, V, VI,
VII, IX
Justify drug therapy
plans based on patient
history and diagnosis
A 5 2, 3, 5 1, 2, 3, 4, 5 1, 2, 3, 4,
5, 6, 7, 8, 9
1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, IV, V,
VI, VII, VIII, IX
Module 4: Endocrine
System
(Week 5)
Met in
(D#/A#/Other)
Course
Outcome(s)
Program
Outcome(s)
SoNGoals AACN
Masters
Essentials
Social
Change
Features
University
Outcome(s)
Differentiate types of
diabetes
D 3 3 1, 2, 3, 4, 5 1, 3, 6, 7, 9 1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, V, VI,
VII, IX
Evaluate the impact of
diabetes drugs on
D 2, 4 3, 5 1, 2, 3, 4, 5 1, 3, 4, 5,
6, 7, 8, 9
1, 2, 3, 4,
5, 6, 7, 8,
I, II, III, V, VI,
VII, VIII, IX
© 2021 Walden University, LLC Page 7 of 10
patients 9
Evaluatealternative
drug treatments and
patient education
strategies and diabetes
management
D 4, 5 2, 3, 4, 5 1, 2, 3, 4, 5 1, 2, 3, 4,
5, 6, 7, 8, 9
1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, IV, V,
VI, VII, VIII, IX
Module 5: Neurologic
andMusculoskeletal
Systems and
Opioids
Met in
(D#/A#/Other)
Course
Outcome(s)
Program
Outcome(s)
SoNGoals AACN
Masters
Essentials
Social
Change
Features
University
Outcome(s)
Evaluate patients for
treatment of neurological
andmusculoskeletal
disorders
A* 2 3 1, 2, 3, 4, 5 1, 3, 6, 7, 9 1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, V, VI,
VII, IX
Analyze decisions made
throughout the diagnosis
and treatment of
patients with
neurological and
musculoskeletal
disorders
A* 2, 3, 4 2, 3, 5, 7 1, 2, 3, 4, 5 1, 2, 3, 4,
5, 6, 7, 8, 9
1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, IV, V,
VI, VII, VIII, IX
Justify decisions made
throughout the diagnosis
and treatment of
patients with
neurological and
musculoskeletal
disorders
A* 5 2, 3, 5, 7 1, 2, 3, 4, 5 1, 2, 3, 4,
5, 6, 7, 8, 9
1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, IV, V,
VI, VII, VIII, IX
Identify key terms,
concepts, and principles
related to prescribing
drugs to treat patient
ME 1, 2, 5, 6 2, 3, 5, 7 1, 2, 3, 4, 5 1, 2, 3, 4,
5, 6, 7, 8, 9
1, 2, 3, 4,
5, 6, 7, 8
I, II, III, IV, V,
VI, VII, VIII, IX
© 2021 Walden University, LLC Page 8 of 10
disorders
Module 6:
Pharmacologyof
Psychological
Disorders
(Week 8)
Met in
(D#/A#/Other)
Course
Outcome(s)
Program
Outcome(s)
SoNGoals AACN
Masters
Essentials
Social
Change
Features
University
Outcome(s)
Evaluate patients for
treatment of
psychological disorders
D 2 3 1, 2, 3, 4, 5 1, 3, 6, 7, 9 1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, V, VI,
VII, IX
Analyze decisions made
throughout the diagnosis
and treatment of
patients with
psychological disorders
D 2, 3, 4 2, 3, 5, 7 1, 2, 3, 4, 5 1, 2, 3, 4,
5, 6, 7, 8, 9
1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, IV, V,
VI, VII, VIII, IX
Analyze impacts of
pharmacotherapeutics
for psychological
disorders on patient
pathophysiology
D 4 3 1, 2, 3, 4, 5 1, 3, 6, 7, 9 1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, V, VI,
VII, IX
Evaluate patients for
treatment of neurological
andmusculoskeletal
disorders
A 2 3 1, 2, 3, 4, 5 1, 3, 6, 7, 9 1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, V, VI,
VII, IX
Analyze decisions made
throughout the diagnosis
and treatment of
patients with
neurological and
musculoskeletal
disorders
A 2, 3, 4 2, 3, 5, 7 1, 2, 3, 4, 5 1, 2, 3, 4,
5, 6, 7, 8, 9
1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, IV, V,
VI, VII, VIII, IX
© 2021 Walden University, LLC Page 9 of 10
Module 7: Women’s
and Men’s Health,
Infections, and
Hematologic Systems
(Weeks 9-10)
Met in
(D#/A#/Other)
Course
Outcome(s)
Program
Outcome(s)
SoNGoals AACN
Masters
Essentials
Social
Change
Features
University
Outcome(s)
Evaluate patients for
treatment of women’s
and men’s health issues
D 2 3 1, 2, 3, 4, 5 1, 3, 6, 7, 9 1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, V, VI,
VII, IX
Evaluate patients for
treatment of infections
D 2 3 1, 2, 3, 4, 5 1, 3, 6, 7, 9 1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, V, VI,
VII, IX
Evaluate patients for
treatment of hematologic
disorders
D 2 3 1, 2, 3, 4, 5 1, 3, 6, 7, 9 1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, V, VI,
VII, IX
Analyzepatient
education strategies for
the management and
treatment of complex
comorbidities
D 4, 5 2, 5, 7 1, 2, 3, 4, 5 1, 2, 3, 4,
5, 6, 8, 9
1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, IV, V,
VI, VII, VIII, IX
Module 8: Pediatrics
(Week 11)
Met in
(D#/A#/Other)
Course
Outcome(s)
Program
Outcome(s)
SoNGoals AACN
Masters
Essentials
Social
Change
Features
University
Outcome(s)
Evaluate the practice of
prescribingoff-label
drugs to children
A 4, 5, 6 3 1, 2, 3, 4, 5 1, 3, 6, 7, 9 1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, V, VI,
VII, IX
© 2021 Walden University, LLC Page 10 of 10
Analyze strategies to
make the off-label use of
drugs safer for children
A 6 2, 6, 7 1, 2, 3, 4, 5 1, 2, 3, 4,
5, 6, 8, 9
1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, IV, V,
VI, VII, VIII, IX
Identify key terms,
concepts, and principles
related to prescribing
drugs to treat patient
disorders
FE 1, 2, 3, 4, 5,
6
2, 3, 5, 7 1, 2, 3, 4, 5 1, 2, 3, 4,
5, 6, 7, 8, 9
1, 2, 3, 4,
5, 6, 7, 8,
9
I, II, III, IV, V,
VI, VII, VIII, IX

Dont wait until the last minute.

Provide your requirements and let our native nursing writers deliver your assignments ASAP.

Start My Order